Legacy Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,010
Closed -$238K 137
2020
Q2
$238K Buy
+1,010
New +$230K 0.1% 126
2019
Q2
Sell
-2,410
Closed -$458K 142
2019
Q1
$458K Sell
2,410
-1,475
-38% -$282K 0.21% 90
2018
Q4
$756K Sell
3,885
-75
-2% -$14.6K 0.4% 65
2018
Q3
$822K Sell
3,960
-450
-10% -$88.7K 0.38% 66
2018
Q2
$814K Buy
4,410
+360
+9% +$63.7K 0.4% 66
2018
Q1
$690K Sell
4,050
-50
-1% -$9.18K 0.35% 69
2017
Q4
$713K Sell
4,100
-250
-6% -$44.2K 0.35% 64
2017
Q3
$811K Hold
4,350
0.43% 59
2017
Q2
$749K Sell
4,350
-350
-7% -$56.9K 0.41% 65
2017
Q1
$772K Sell
4,700
-125
-3% -$20.8K 0.43% 60
2016
Q4
$706K Sell
4,825
-525
-10% -$79K 0.43% 64
2016
Q3
$893K Buy
5,350
+100
+2% +$16.9K 0.56% 55
2016
Q2
$799K Buy
+5,250
New +$816K 0.5% 60

Other funds holding AMGN

Legacy Capital Partners's AMGN Position: Q3 2020 in Review

Legacy Capital Partners sold out of Amgen (AMGN) in Q3 2020, closing a stake of 1,010 shares — an estimated $238K sold.

Legacy Capital Partners first reported a position in AMGN in Q2 2016 and held it in 13 quarters. The position peaked at $893K in Q3 2016. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Legacy Capital Partners reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Legacy Capital Partners sold 1,010 Amgen shares in Q3 2020, an estimated $238K.
  • Legacy Capital Partners first reported a position in Amgen in Q2 2016 and held it in 13 quarters.
  • Legacy Capital Partners's Amgen position peaked at $893K in Q3 2016.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Legacy Capital Partners's 13F filing for Q3 2020, filed 13 Oct 2020.